VIVEbiotech’s R&D department works in several areas. Therefore, once the desired results are achieved, they can be transferred to the services provided to our customers:

Improve producer cell lines, including the possibility of genetic modification to:

  • Enhance productivity.
  • Increase tropism.
  • Optimize expansion.
  • Obtain a stable cell line.

Develop new analytical methods to:

  • Better understand our process and/or product.
  • Improve analytical methods for batch release.

Different pseudotyping strategies.


Worldwide licensed technology (WO 2015/078999 A1) consisting of a non-integrative episomal stable lentiviral vector that provides a lasting, stable, consistent expression of the transgene in dividing and non-dividing cells.